Donepezil Hydrochloride API
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Olmesartan API Market Research Report 2023
1 Olmesartan API Market Overview
1.1 Product Overview and Scope of Olmesartan API
1.2 Olmesartan API Segment by Type
1.2.1 Global Olmesartan API Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Purity 99%
1.2.3 Purity > 99%
1.3 Olmesartan API Segment by Application
1.3.1 Global Olmesartan API Sales Comparison by Application: (2022-2028)
1.3.2 Tablet Products
1.3.3 Capsule Products
1.3.4 Others
1.4 Global Olmesartan API Market Size Estimates and Forecasts
1.4.1 Global Olmesartan API Revenue 2017-2028
1.4.2 Global Olmesartan API Sales 2017-2028
1.4.3 Olmesartan API Market Size by Region: 2017 Versus 2021 Versus 2028
2 Olmesartan API Market Competition by Manufacturers
2.1 Global Olmesartan API Sales Market Share by Manufacturers (2017-2022)
2.2 Global Olmesartan API Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Olmesartan API Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Olmesartan API Manufacturing Sites, Area Served, Product Type
2.5 Olmesartan API Market Competitive Situation and Trends
2.5.1 Olmesartan API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Olmesartan API Players Market Share by Revenue
2.5.3 Global Olmesartan API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Olmesartan API Retrospective Market Scenario by Region
3.1 Global Olmesartan API Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Olmesartan API Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Olmesartan API Market Facts & Figures by Country
3.3.1 North America Olmesartan API Sales by Country
3.3.2 North America Olmesartan API Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Olmesartan API Market Facts & Figures by Country
3.4.1 Europe Olmesartan API Sales by Country
3.4.2 Europe Olmesartan API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Olmesartan API Market Facts & Figures by Region
3.5.1 Asia Pacific Olmesartan API Sales by Region
3.5.2 Asia Pacific Olmesartan API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Olmesartan API Market Facts & Figures by Country
3.6.1 Latin America Olmesartan API Sales by Country
3.6.2 Latin America Olmesartan API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Olmesartan API Market Facts & Figures by Country
3.7.1 Middle East and Africa Olmesartan API Sales by Country
3.7.2 Middle East and Africa Olmesartan API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Olmesartan API Historic Market Analysis by Type
4.1 Global Olmesartan API Sales Market Share by Type (2017-2022)
4.2 Global Olmesartan API Revenue Market Share by Type (2017-2022)
4.3 Global Olmesartan API Price by Type (2017-2022)
5 Global Olmesartan API Historic Market Analysis by Application
5.1 Global Olmesartan API Sales Market Share by Application (2017-2022)
5.2 Global Olmesartan API Revenue Market Share by Application (2017-2022)
5.3 Global Olmesartan API Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Coba Pharma
6.1.1 Coba Pharma Corporation Information
6.1.2 Coba Pharma Description and Business Overview
6.1.3 Coba Pharma Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Coba Pharma Olmesartan API Product Portfolio
6.1.5 Coba Pharma Recent Developments/Updates
6.2 Acura Labs
6.2.1 Acura Labs Corporation Information
6.2.2 Acura Labs Description and Business Overview
6.2.3 Acura Labs Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Acura Labs Olmesartan API Product Portfolio
6.2.5 Acura Labs Recent Developments/Updates
6.3 Interquim
6.3.1 Interquim Corporation Information
6.3.2 Interquim Description and Business Overview
6.3.3 Interquim Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Interquim Olmesartan API Product Portfolio
6.3.5 Interquim Recent Developments/Updates
6.4 Euro API
6.4.1 Euro API Corporation Information
6.4.2 Euro API Description and Business Overview
6.4.3 Euro API Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Euro API Olmesartan API Product Portfolio
6.4.5 Euro API Recent Developments/Updates
6.5 Biophore India Pharmaceuticals
6.5.1 Biophore India Pharmaceuticals Corporation Information
6.5.2 Biophore India Pharmaceuticals Description and Business Overview
6.5.3 Biophore India Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Biophore India Pharmaceuticals Olmesartan API Product Portfolio
6.5.5 Biophore India Pharmaceuticals Recent Developments/Updates
6.6 Jai Radhe
6.6.1 Jai Radhe Corporation Information
6.6.2 Jai Radhe Description and Business Overview
6.6.3 Jai Radhe Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Jai Radhe Olmesartan API Product Portfolio
6.6.5 Jai Radhe Recent Developments/Updates
6.7 Summit Pharmaceuticals Europe
6.6.1 Summit Pharmaceuticals Europe Corporation Information
6.6.2 Summit Pharmaceuticals Europe Description and Business Overview
6.6.3 Summit Pharmaceuticals Europe Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Summit Pharmaceuticals Europe Olmesartan API Product Portfolio
6.7.5 Summit Pharmaceuticals Europe Recent Developments/Updates
6.8 Octavius Pharma Pvt. Ltd
6.8.1 Octavius Pharma Pvt. Ltd Corporation Information
6.8.2 Octavius Pharma Pvt. Ltd Description and Business Overview
6.8.3 Octavius Pharma Pvt. Ltd Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Octavius Pharma Pvt. Ltd Olmesartan API Product Portfolio
6.8.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates
6.9 Zeon Health lndustries
6.9.1 Zeon Health lndustries Corporation Information
6.9.2 Zeon Health lndustries Description and Business Overview
6.9.3 Zeon Health lndustries Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Zeon Health lndustries Olmesartan API Product Portfolio
6.9.5 Zeon Health lndustries Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Sanofi Olmesartan API Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Glenmark Pharmaceuticals Europe
6.11.1 Glenmark Pharmaceuticals Europe Corporation Information
6.11.2 Glenmark Pharmaceuticals Europe Olmesartan API Description and Business Overview
6.11.3 Glenmark Pharmaceuticals Europe Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Glenmark Pharmaceuticals Europe Olmesartan API Product Portfolio
6.11.5 Glenmark Pharmaceuticals Europe Recent Developments/Updates
6.12 Verdant Pharma
6.12.1 Verdant Pharma Corporation Information
6.12.2 Verdant Pharma Olmesartan API Description and Business Overview
6.12.3 Verdant Pharma Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Verdant Pharma Olmesartan API Product Portfolio
6.12.5 Verdant Pharma Recent Developments/Updates
6.13 Hubei Yitai Pharmaceuticals
6.13.1 Hubei Yitai Pharmaceuticals Corporation Information
6.13.2 Hubei Yitai Pharmaceuticals Olmesartan API Description and Business Overview
6.13.3 Hubei Yitai Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Hubei Yitai Pharmaceuticals Olmesartan API Product Portfolio
6.13.5 Hubei Yitai Pharmaceuticals Recent Developments/Updates
6.14 Ulkar Kimya
6.14.1 Ulkar Kimya Corporation Information
6.14.2 Ulkar Kimya Olmesartan API Description and Business Overview
6.14.3 Ulkar Kimya Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Ulkar Kimya Olmesartan API Product Portfolio
6.14.5 Ulkar Kimya Recent Developments/Updates
6.15 Zhejiang Tianyu Pharmaceutical
6.15.1 Zhejiang Tianyu Pharmaceutical Corporation Information
6.15.2 Zhejiang Tianyu Pharmaceutical Olmesartan API Description and Business Overview
6.15.3 Zhejiang Tianyu Pharmaceutical Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Zhejiang Tianyu Pharmaceutical Olmesartan API Product Portfolio
6.15.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
6.16 Teva API
6.16.1 Teva API Corporation Information
6.16.2 Teva API Olmesartan API Description and Business Overview
6.16.3 Teva API Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Teva API Olmesartan API Product Portfolio
6.16.5 Teva API Recent Developments/Updates
6.17 Zhejiang Huahai Pharmaceutical
6.17.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.17.2 Zhejiang Huahai Pharmaceutical Olmesartan API Description and Business Overview
6.17.3 Zhejiang Huahai Pharmaceutical Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Zhejiang Huahai Pharmaceutical Olmesartan API Product Portfolio
6.17.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.18 Venkata Narayana Active Ingredients
6.18.1 Venkata Narayana Active Ingredients Corporation Information
6.18.2 Venkata Narayana Active Ingredients Olmesartan API Description and Business Overview
6.18.3 Venkata Narayana Active Ingredients Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Venkata Narayana Active Ingredients Olmesartan API Product Portfolio
6.18.5 Venkata Narayana Active Ingredients Recent Developments/Updates
6.19 Cadila Pharmaceuticals
6.19.1 Cadila Pharmaceuticals Corporation Information
6.19.2 Cadila Pharmaceuticals Olmesartan API Description and Business Overview
6.19.3 Cadila Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Cadila Pharmaceuticals Olmesartan API Product Portfolio
6.19.5 Cadila Pharmaceuticals Recent Developments/Updates
6.20 Unimark Remedies
6.20.1 Unimark Remedies Corporation Information
6.20.2 Unimark Remedies Olmesartan API Description and Business Overview
6.20.3 Unimark Remedies Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Unimark Remedies Olmesartan API Product Portfolio
6.20.5 Unimark Remedies Recent Developments/Updates
6.21 Vasudha Pharma
6.21.1 Vasudha Pharma Corporation Information
6.21.2 Vasudha Pharma Olmesartan API Description and Business Overview
6.21.3 Vasudha Pharma Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Vasudha Pharma Olmesartan API Product Portfolio
6.21.5 Vasudha Pharma Recent Developments/Updates
6.22 Macleods Pharmaceuticals
6.22.1 Macleods Pharmaceuticals Corporation Information
6.22.2 Macleods Pharmaceuticals Olmesartan API Description and Business Overview
6.22.3 Macleods Pharmaceuticals Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Macleods Pharmaceuticals Olmesartan API Product Portfolio
6.22.5 Macleods Pharmaceuticals Recent Developments/Updates
6.23 Mylan
6.23.1 Mylan Corporation Information
6.23.2 Mylan Olmesartan API Description and Business Overview
6.23.3 Mylan Olmesartan API Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Mylan Olmesartan API Product Portfolio
6.23.5 Mylan Recent Developments/Updates
7 Olmesartan API Manufacturing Cost Analysis
7.1 Olmesartan API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Olmesartan API
7.4 Olmesartan API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Olmesartan API Distributors List
8.3 Olmesartan API Customers
9 Olmesartan API Market Dynamics
9.1 Olmesartan API Industry Trends
9.2 Olmesartan API Market Drivers
9.3 Olmesartan API Market Challenges
9.4 Olmesartan API Market Restraints
10 Global Market Forecast
10.1 Olmesartan API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Olmesartan API by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Olmesartan API by Type (2023-2028)
10.2 Olmesartan API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Olmesartan API by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Olmesartan API by Application (2023-2028)
10.3 Olmesartan API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Olmesartan API by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Olmesartan API by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Olmesartan API Sales Growth Rate Comparison by Type (2022-2028) & (Tons) & (US$ Million)
Table 2. Global Olmesartan API Sales Growth Rate Comparison by Application (2022-2028) & (Tons) & (US$ Million)
Table 3. Global Olmesartan API Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Olmesartan API Market Competitive Situation by Manufacturers in 2021
Table 5. Global Olmesartan API Sales (Tons) of Key Manufacturers (2017-2022)
Table 6. Global Olmesartan API Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Olmesartan API Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Olmesartan API Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Olmesartan API Average Price (US$/Kg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Olmesartan API Manufacturing Sites and Area Served
Table 11. Manufacturers Olmesartan API Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Olmesartan API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Olmesartan API as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Olmesartan API Sales by Region (2017-2022) & (Tons)
Table 16. Global Olmesartan API Sales Market Share by Region (2017-2022)
Table 17. Global Olmesartan API Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Olmesartan API Revenue Market Share by Region (2017-2022)
Table 19. North America Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 20. North America Olmesartan API Sales Market Share by Country (2017-2022)
Table 21. North America Olmesartan API Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Olmesartan API Revenue Market Share by Country (2017-2022)
Table 23. Europe Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 24. Europe Olmesartan API Sales Market Share by Country (2017-2022)
Table 25. Europe Olmesartan API Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Olmesartan API Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Olmesartan API Sales by Region (2017-2022) & (Tons)
Table 28. Asia Pacific Olmesartan API Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Olmesartan API Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Olmesartan API Revenue Market Share by Region (2017-2022)
Table 31. Latin America Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 32. Latin America Olmesartan API Sales Market Share by Country (2017-2022)
Table 33. Latin America Olmesartan API Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Olmesartan API Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 36. Middle East and Africa Olmesartan API Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Olmesartan API Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Olmesartan API Revenue Market Share by Country (2017-2022)
Table 39. Global Olmesartan API Sales by Type (2017-2022) & (Tons)
Table 40. Global Olmesartan API Sales Market Share by Type (2017-2022)
Table 41. Global Olmesartan API Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Olmesartan API Revenue Share by Type (2017-2022)
Table 43. Global Olmesartan API Price by Type (2017-2022) & (US$/Kg)
Table 44. Global Olmesartan API Sales (Tons) by Application (2017-2022)
Table 45. Global Olmesartan API Sales Market Share by Application (2017-2022)
Table 46. Global Olmesartan API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Olmesartan API Revenue Share by Application (2017-2022)
Table 48. Global Olmesartan API Price by Application (2017-2022) & (US$/Kg)
Table 49. Coba Pharma Corporation Information
Table 50. Coba Pharma Description and Business Overview
Table 51. Coba Pharma Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 52. Coba Pharma Olmesartan API Product
Table 53. Coba Pharma Recent Developments/Updates
Table 54. Acura Labs Corporation Information
Table 55. Acura Labs Description and Business Overview
Table 56. Acura Labs Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 57. Acura Labs Olmesartan API Product
Table 58. Acura Labs Recent Developments/Updates
Table 59. Interquim Corporation Information
Table 60. Interquim Description and Business Overview
Table 61. Interquim Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 62. Interquim Olmesartan API Product
Table 63. Interquim Recent Developments/Updates
Table 64. Euro API Corporation Information
Table 65. Euro API Description and Business Overview
Table 66. Euro API Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 67. Euro API Olmesartan API Product
Table 68. Euro API Recent Developments/Updates
Table 69. Biophore India Pharmaceuticals Corporation Information
Table 70. Biophore India Pharmaceuticals Description and Business Overview
Table 71. Biophore India Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 72. Biophore India Pharmaceuticals Olmesartan API Product
Table 73. Biophore India Pharmaceuticals Recent Developments/Updates
Table 74. Jai Radhe Corporation Information
Table 75. Jai Radhe Description and Business Overview
Table 76. Jai Radhe Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 77. Jai Radhe Olmesartan API Product
Table 78. Jai Radhe Recent Developments/Updates
Table 79. Summit Pharmaceuticals Europe Corporation Information
Table 80. Summit Pharmaceuticals Europe Description and Business Overview
Table 81. Summit Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 82. Summit Pharmaceuticals Europe Olmesartan API Product
Table 83. Summit Pharmaceuticals Europe Recent Developments/Updates
Table 84. Octavius Pharma Pvt. Ltd Corporation Information
Table 85. Octavius Pharma Pvt. Ltd Description and Business Overview
Table 86. Octavius Pharma Pvt. Ltd Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 87. Octavius Pharma Pvt. Ltd Olmesartan API Product
Table 88. Octavius Pharma Pvt. Ltd Recent Developments/Updates
Table 89. Zeon Health lndustries Corporation Information
Table 90. Zeon Health lndustries Description and Business Overview
Table 91. Zeon Health lndustries Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 92. Zeon Health lndustries Olmesartan API Product
Table 93. Zeon Health lndustries Recent Developments/Updates
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 97. Sanofi Olmesartan API Product
Table 98. Sanofi Recent Developments/Updates
Table 99. Glenmark Pharmaceuticals Europe Corporation Information
Table 100. Glenmark Pharmaceuticals Europe Description and Business Overview
Table 101. Glenmark Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 102. Glenmark Pharmaceuticals Europe Olmesartan API Product
Table 103. Glenmark Pharmaceuticals Europe Recent Developments/Updates
Table 104. Verdant Pharma Corporation Information
Table 105. Verdant Pharma Description and Business Overview
Table 106. Verdant Pharma Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 107. Verdant Pharma Olmesartan API Product
Table 108. Verdant Pharma Recent Developments/Updates
Table 109. Hubei Yitai Pharmaceuticals Corporation Information
Table 110. Hubei Yitai Pharmaceuticals Description and Business Overview
Table 111. Hubei Yitai Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 112. Hubei Yitai Pharmaceuticals Olmesartan API Product
Table 113. Hubei Yitai Pharmaceuticals Recent Developments/Updates
Table 114. Ulkar Kimya Corporation Information
Table 115. Ulkar Kimya Description and Business Overview
Table 116. Ulkar Kimya Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. Ulkar Kimya Olmesartan API Product
Table 118. Ulkar Kimya Recent Developments/Updates
Table 119. Zhejiang Tianyu Pharmaceutical Corporation Information
Table 120. Zhejiang Tianyu Pharmaceutical Description and Business Overview
Table 121. Zhejiang Tianyu Pharmaceutical Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Zhejiang Tianyu Pharmaceutical Olmesartan API Product
Table 123. Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
Table 124. Teva API Corporation Information
Table 125. Teva API Description and Business Overview
Table 126. Teva API Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Teva API Olmesartan API Product
Table 128. Teva API Recent Developments/Updates
Table 129. Zhejiang Huahai Pharmaceutical Corporation Information
Table 130. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 131. Zhejiang Huahai Pharmaceutical Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 132. Zhejiang Huahai Pharmaceutical Olmesartan API Product
Table 133. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 134. Venkata Narayana Active Ingredients Corporation Information
Table 135. Venkata Narayana Active Ingredients Description and Business Overview
Table 136. Venkata Narayana Active Ingredients Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 137. Venkata Narayana Active Ingredients Olmesartan API Product
Table 138. Venkata Narayana Active Ingredients Recent Developments/Updates
Table 139. Cadila Pharmaceuticals Corporation Information
Table 140. Cadila Pharmaceuticals Description and Business Overview
Table 141. Cadila Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 142. Cadila Pharmaceuticals Olmesartan API Product
Table 143. Cadila Pharmaceuticals Recent Developments/Updates
Table 144. Unimark Remedies Corporation Information
Table 145. Unimark Remedies Description and Business Overview
Table 146. Unimark Remedies Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 147. Unimark Remedies Olmesartan API Product
Table 148. Unimark Remedies Recent Developments/Updates
Table 149. Vasudha Pharma Corporation Information
Table 150. Vasudha Pharma Description and Business Overview
Table 151. Vasudha Pharma Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 152. Vasudha Pharma Olmesartan API Product
Table 153. Vasudha Pharma Recent Developments/Updates
Table 154. Macleods Pharmaceuticals Corporation Information
Table 155. Macleods Pharmaceuticals Description and Business Overview
Table 156. Macleods Pharmaceuticals Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 157. Macleods Pharmaceuticals Olmesartan API Product
Table 158. Macleods Pharmaceuticals Recent Developments/Updates
Table 159. Mylan Corporation Information
Table 160. Mylan Description and Business Overview
Table 161. Mylan Olmesartan API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 162. Mylan Olmesartan API Product
Table 163. Mylan Recent Developments/Updates
Table 164. Production Base and Market Concentration Rate of Raw Material
Table 165. Key Suppliers of Raw Materials
Table 166. Olmesartan API Distributors List
Table 167. Olmesartan API Customers List
Table 168. Olmesartan API Market Trends
Table 169. Olmesartan API Market Drivers
Table 170. Olmesartan API Market Challenges
Table 171. Olmesartan API Market Restraints
Table 172. Global Olmesartan API Sales Forecast by Type (2023-2028) & (Tons)
Table 173. Global Olmesartan API Sales Market Share Forecast by Type (2023-2028)
Table 174. Global Olmesartan API Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 175. Global Olmesartan API Revenue Market Share Forecast by Type (2023-2028)
Table 176. Global Olmesartan API Sales Forecast by Application (2023-2028) & (Tons)
Table 177. Global Olmesartan API Sales Market Share Forecast by Application (2023-2028)
Table 178. Global Olmesartan API Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 179. Global Olmesartan API Revenue Market Share Forecast by Application (2023-2028)
Table 180. Global Olmesartan API Sales Forecast by Region (2023-2028) & (Tons)
Table 181. Global Olmesartan API Sales Market Share Forecast by Region (2023-2028)
Table 182. Global Olmesartan API Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 183. Global Olmesartan API Revenue Market Share Forecast by Region (2023-2028)
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Olmesartan API
Figure 2. Global Olmesartan API Market Share by Type in 2021 & 2028
Figure 3. Purity 99% Product Picture
Figure 4. Purity > 99% Product Picture
Figure 5. Global Olmesartan API Market Share by Application in 2021 & 2028
Figure 6. Tablet Products
Figure 7. Capsule Products
Figure 8. Others
Figure 9. Global Olmesartan API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Olmesartan API Market Size (2017-2028) & (US$ Million)
Figure 11. Global Olmesartan API Sales (2017-2028) & (Tons)
Figure 12. Olmesartan API Sales Share by Manufacturers in 2021
Figure 13. Global Olmesartan API Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Olmesartan API Players: Market Share by Revenue in 2021
Figure 15. Olmesartan API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Olmesartan API Sales Market Share by Region (2017-2022)
Figure 17. Global Olmesartan API Sales Market Share by Region in 2021
Figure 18. Global Olmesartan API Revenue Market Share by Region (2017-2022)
Figure 19. Global Olmesartan API Revenue Market Share by Region in 2021
Figure 20. United States Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Olmesartan API Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Olmesartan API by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Olmesartan API
Figure 44. Manufacturing Process Analysis of Olmesartan API
Figure 45. Olmesartan API Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Coba Pharma Acura Labs Interquim Euro API Biophore India Pharmaceuticals Jai Radhe Summit Pharmaceuticals Europe Octavius Pharma Pvt. Ltd Zeon Health lndustries Sanofi Glenmark Pharmaceuticals Europe Verdant Pharma Hubei Yitai Pharmaceuticals Ulkar Kimya Zhejiang Tianyu Pharmaceutical Teva API Zhejiang Huahai Pharmaceutical Venkata Narayana Active Ingredients Cadila Pharmaceuticals Unimark Remedies Vasudha Pharma Macleods Pharmaceuticals Mylan